Watch and Wait Approach for Rectal Cancer.
Carlos Cerdán SantacruzGuilherme Pagin São JuliãoBruna Borba VailatiLeonardo CorbiAngelita Habr-GamaRodrigo Oliva PerezPublished in: Journal of clinical medicine (2023)
The administration of neoadjuvant chemoradiotherapy (nCRT) followed by total mesorrectal excision (TME) and selective use of adjuvant chemotherapy can still be considered the standard of care in locally advanced rectal cancer (LARC). However, avoiding sequelae of TME and entering a narrow follow-up program of watch and wait (W&W), in select cases that achieve a comparable clinical complete response (cCR) to nCRT, is now very attractive to both patients and clinicians. Many advances based on well-designed studies and long-term data coming from big multicenter cohorts have drawn some important conclusions and warnings regarding this strategy. In order to safely implement W&W, it is important consider proper selection of cases, best treatment options, surveillance strategy and the attitudes towards near complete responses or even tumor regrowth. The present review offers a comprehensive overview of W&W strategy from its origins to the most current literature, from a practical point of view focused on daily clinical practice, without losing sight of the most important future prospects in this area.
Keyphrases
- rectal cancer
- locally advanced
- neoadjuvant chemotherapy
- phase ii study
- squamous cell carcinoma
- end stage renal disease
- clinical practice
- radiation therapy
- palliative care
- quality improvement
- ejection fraction
- big data
- chronic kidney disease
- systematic review
- current status
- newly diagnosed
- healthcare
- electronic health record
- clinical trial
- public health
- regulatory t cells
- machine learning
- prognostic factors
- pain management
- cross sectional
- patient reported